share_log

LifeSci Capital Downgrades Repare Therapeutics to Market Perform

Benzinga ·  Dec 14, 2024 03:39

LifeSci Capital analyst Charles Zhu downgrades Repare Therapeutics (NASDAQ:RPTX) from Outperform to Market Perform.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment